Celgene, Bristol-Myers monopolised cancer drug, pharmacies say

Celgene, Bristol-Myers Squibb and two generic drugmakers engaged in a years-long conspiracy to hinder generic competition for a rare cancer medication, Walgreens and Kroger Pharmacies have alleged.

Unlock unlimited access to all Global Competition Review content